Press coverage about ReWalk Robotics (NASDAQ:RWLK) has been trending somewhat positive this week, according to Accern Sentiment. Accern identifies negative and positive news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. ReWalk Robotics earned a coverage optimism score of 0.20 on Accern’s scale. Accern also assigned news headlines about the medical device company an impact score of 46.9655687672683 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Here are some of the headlines that may have impacted Accern Sentiment Analysis’s analysis:

Several analysts recently issued reports on RWLK shares. Canaccord Genuity dropped their price objective on shares of ReWalk Robotics from $4.00 to $3.00 and set a “buy” rating for the company in a research note on Friday, August 4th. Oppenheimer Holdings, Inc. set a $4.00 price objective on shares of ReWalk Robotics and gave the company a “buy” rating in a research note on Friday, August 4th. Finally, Jefferies Group LLC dropped their price objective on shares of ReWalk Robotics from $8.00 to $5.00 and set a “buy” rating for the company in a research note on Friday. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company. ReWalk Robotics presently has a consensus rating of “Hold” and an average price target of $3.38.

Shares of ReWalk Robotics (NASDAQ RWLK) remained flat at $$1.43 during midday trading on Tuesday. 115,305 shares of the stock were exchanged, compared to its average volume of 241,508. ReWalk Robotics has a fifty-two week low of $1.10 and a fifty-two week high of $3.60. The company has a debt-to-equity ratio of 7.46, a quick ratio of 1.65 and a current ratio of 2.02.

ReWalk Robotics (NASDAQ:RWLK) last announced its quarterly earnings data on Thursday, November 2nd. The medical device company reported ($0.22) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.32) by $0.10. ReWalk Robotics had a negative net margin of 346.14% and a negative return on equity of 568.25%. The company had revenue of $1.70 million during the quarter, compared to analysts’ expectations of $1.63 million. During the same quarter in the prior year, the company earned ($0.62) EPS. ReWalk Robotics’s revenue was up 21.4% compared to the same quarter last year. equities analysts expect that ReWalk Robotics will post -1.27 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: “ReWalk Robotics (RWLK) Given News Impact Score of 0.20” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this article on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark legislation. The correct version of this article can be read at

ReWalk Robotics Company Profile

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement.

Insider Buying and Selling by Quarter for ReWalk Robotics (NASDAQ:RWLK)

Receive News & Stock Ratings for ReWalk Robotics Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics Ltd and related stocks with our FREE daily email newsletter.